CombiGene’s preference issue, amounting to 31 million kronor, oversubscribed

The subscription period for a preference share issue in CombiGene AB (“CombiGene” or “the Company”) amounting to about MSEK 31 ended on 18 September 2018. The preference issue was subscribed to about MSEK 46, which corresponds to a subscription rate of about 148 percent. The issue will generate about MSEK 31.0 before deductions for issuing expenses. Consequently, the issue guarantees have not been utilized. Contract notes are expected to be sent today, 21 September 2018.
Read pressrelease >>

“This is an English translation of the Swedish website; if there is any inconsistency or ambiguity between the English version and the Swedish version, the Swedish version shall prevail. For a complete list of regulatory-related press releases, please refer to the Swedish website”